|
UQCC expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.46112069297078E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.10110040477218E-10 |
| Normal-vs-Stage2 |
1.690200E-01 |
| Normal-vs-Stage3 |
5.32907051820075E-13 |
| Normal-vs-Stage4 |
1.7412737918221E-12 |
| Stage1-vs-Stage2 |
9.821300E-04 |
| Stage1-vs-Stage3 |
1.928490E-02 |
| Stage1-vs-Stage4 |
1.238440E-03 |
| Stage2-vs-Stage3 |
1.87522999999246E-05 |
| Stage2-vs-Stage4 |
5.35930000045148E-07 |
| Stage3-vs-Stage4 |
1.783220E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.2312373343093E-13 |
| Normal-vs-AfricanAmerican |
1.05849999998409E-06 |
| Normal-vs-Asian |
2.18119999999544E-05 |
| Caucasian-vs-AfricanAmerican |
9.883000E-01 |
| Caucasian-vs-Asian |
2.307900E-02 |
| AfricanAmerican-vs-Asian |
1.199420E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.75909994640733E-10 |
| Normal-vs-Female |
5.10429476463514E-11 |
| Male-vs-Female |
9.897800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.71369951352096E-10 |
| Normal-vs-Age(41-60Yrs) |
1.11189946139234E-10 |
| Normal-vs-Age(61-80Yrs) |
1.65979999744437E-08 |
| Normal-vs-Age(81-100Yrs) |
2.596000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.297800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.094200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.685600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.705600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.219800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.278800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.24820000019832E-07 |
| Classical-VS-Follicular |
1.30410000021008E-07 |
| Classical-VS-Other |
6.861400E-01 |
| Classical-VS-Normal |
1.94544380605066E-12 |
| Tall-VS-Follicular |
1.65734093116043E-12 |
| Tall-VS-Other |
6.743800E-02 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
4.305700E-02 |
| Follicular-VS-Normal |
5.075500E-02 |
| Other-VS-Normal |
5.205400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.96190000304009E-08 |
| Normal-vs-N1 |
1.95830018867582E-10 |
| N0-vs-N1 |
3.642500E-03 |
|
|
